Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector

New Publication by HI-STEM: Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML

New Publication by HI-STEM: Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AML

From Research to Everyday Life: App Speeds Up Information Flow for Rare Metabolic Disorders

From Research to Everyday Life: App Speeds Up Information Flow for Rare Metabolic Disorders

Tracing environmental change through river microbiomes in Luxembourg 

Tracing environmental change through river microbiomes in Luxembourg 

Connecting tissue physical changes to what developing cells become

Connecting tissue physical changes to what developing cells become

Hummingbird Diagnostics to Present New Findings Linking Ribosome Quality Control Pathway to Liquid Biopsy Biomarkers for Lung Cancer at EACR

Hummingbird Diagnostics to Present New Findings Linking Ribosome Quality Control Pathway to Liquid Biopsy Biomarkers for Lung Cancer at EACR

Why pain persists long after injuries have healed

Why pain persists long after injuries have healed

New HI-STEM Publication: A kinetics-based model of haematopoiesisreveals extrinsic regulation of skewed lineageoutput from stem cells

New HI-STEM Publication: A kinetics-based model of haematopoiesisreveals extrinsic regulation of skewed lineageoutput from stem cells

Heidelberg-based development revolutionizes hepatitis D therapy worldwide: US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide)

Heidelberg-based development revolutionizes hepatitis D therapy worldwide: US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide)